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Abstract Infections of the brain in the neonatal period
differ considerably from infections in the older child, due to
a variety of age-specific factors that are related not only to
the child, but also to the mother, and to specific pathogenic
organisms. It has been recognized that clinical and
neurological signs are often non-specific, sometimes scarce,
and seldom correlate with the extent of neuroimaging
findings, thus warranting early imaging to ensure timely
therapy and improved outcome.
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Introduction
Infections of the central nervous system (CNS) in neonates
often impede cerebral maturation and result in severe neuro-
developmental delay. This is in particular the case in preterm
babies, whose immunological protection is mainly transmitted
from the mother. MRI is the best modality for demonstrating
both the specific and non-specific expressions of the
inflammatory response to infection in the brain. This paper
reviews the pathogenesis, clinical signs, and the neuroimaging
findings that are frequently seen in the most common
bacterial, viral and fungal brain infections of the neonate,
excluding congenital infections.
Imaging strategy
Cranial US, CT and MRI have all been used for diagnosis
and characterization of neonatal infections, and each
modality has its advantages and disadvantages. For
example, US may be performed bedside in patients who
are critically ill, and can be used for repetitive follow-up
examinations during therapy. Major drawbacks of US are
the incomplete depiction of the brain convexity and the
poor visualisation of posterior fossa abnormalities through
the routinely used acoustic windows. In CT, short scan
times ensure quick delivery of information needed in case
of urgent neurosurgical intervention, but one major draw-
back is the exposure to ionising radiation.
MRI provides excellent anatomical and even functional
detail without the use of ionising radiation; however, scan
times are long, which often requires sedation/anaesthesia.
Besides T1- and T2-weighted images, fluid-attenuated inver-
sion recovery (FLAIR) and diffusion-weighted imaging
(DWI) have been integrated in routine protocols. In neonates
it has been shown that optimal b-values in DWI are between
800 and 1,000 s/mm2, lower than in adults. However, higher
b-values have been shown to enhance contrast between
lesion and normal brain in neonates at 3 Tesla.
Bacterial infection
In general, acute bacterial infections in neonates are divided
into early-onset (first 7 days) and late-onset sepsis. Meningitis
complicates 5–20% of cases of early-onset neonatal sepsis [1],
but clinical symptoms are essentially identical and non-
specific. In the last decade, a significant decrease in
vertically transmitted early-onset sepsis with group B
streptococci (GBS) has been registered in the developed
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world [2], which essentially is due to intrapartum antibiotic
therapy. The incidence of early-onset gram-negative menin-
gitis has been stable. Recent studies found no difference in
outcome between early-onset GBS meningitis and gram-
negative meningitis, but early-onset had poorer outcome that
late-onset GBS meningitis [3, 4]. The most important known
risk factors for sepsis are prematurity [5], lack of maternal
anti-GBS IgG protection [6], placental infections, and
prolonged rupture of the foetal membranes.
CNS damage begins when infectious vasculitis in the
choroid plexus disseminates via the cerebrospinal fluid
leading to ventriculitis. Imaging findings often concur as a
triad: choroid plexus engorgement, avid contrast-
enhancement of the empendyma, and intraventricular accu-
mulation of debris. Periventricular oedema may be related to
bacteria-induced white matter necrosis or to the development
of hydrocephalus. After bacteria have gained access to the
leptomeningeal space, arachnoiditis is induced, but initial
signs of this, like enlargement of the subdural or subarachnoid
spaces, are non-specific and may go unrecognized. On the
other hand, abnormal contrast-enhancement in the arachnoid
may be completely absent in the natural history of GBS
meningitis of the newborn. Eventually, parenchymal invasion
may result in cerebral liquefaction [7]. At the same time,
inflammation of the arachnoid leads to adhesions and
hydrocephalus [8]. In neonates, raised intracranial pressure
and/or cerebral oedema as presenting clinical manifestations
are of particular concern [9–11]. However, the distensibility
of the neonatal cranial vault reduces the risk of fatal
complication in case of brain herniation, which occurs in
approximately 6% of acute meningitis [11].
In early-onset infection, leptomeningeal inflammation is
minimal, despite abundant bacteria, vascular thrombosis
and parenchymal haemorrhage [12]. By contrast, infants
with late-onset disease usually have diffuse purulent
arachnoiditis [7]. These differences reflect the immaturity
of the immunological response in the immediate neonatal
period [13]. Subdural or subarachnoid serous effusions may
result from increased permeability of capillaries and veins
of the dura mater, but these are uncommon in neonates, as
are purulent collections [14]. Inflammation of the arachnoid
may be seen as a “pencil-line” contrast-enhancement over
the gyri, sometimes extending into the sulci (Fig. 1).
Contrast-enhancement in the dura, on the other hand, is
seen as a thickened line underneath the calvarium,
separated by the subdural space from the arachnoid
membrane opposite. Dural enhancement may persist several
months after complete clinical recovery. Before true
purulent leptomeningeal accumulation occurs, the intense
inflammatory reaction produces cellular debris from leuco-
cytic infiltrates and fibrin or protein residues, which can be
seen as high signal intensity within the CSF spaces on
FLAIR images (Fig. 2). DWI is very accurate for purulent
collections because of the higher viscosity of these fluids
(restricted diffusion), and will consistently demonstrate
striking hyperintensity even before signal changes appear
on FLAIR, T1- or T2-weighted images (Fig. 3).
Parenchymal extension may cause brain abscesses.
Citrobacter and Proteus genus were reported as causative
organisms of brain abscess in most children younger than
1 month, while Streptococcus species were the most
common isolates thereafter [15, 16]. There is a continuous
development from focal cerebritis (with vasculitis, hae-
morrhage and surrounding oedema) to mature abscess
(with central necrosis and a peripheral inflammatory
capsule), a process that takes 2–3 weeks, although it may
only take a few days in neonates [17]. Differences in
Fig. 1 Pneumococcus meningitis. The subarachnoid and subdural
spaces over the left hemisphere are enlarged. After contrast medium
administration, the thickened arachnoid (double arrow) and dura
(curved arrow) enhance avidly
Fig. 2 Pneumococcus meningitis. Fluid-attenuated inversion recovery
(FLAIR) MRI shows a hyperintense subdural inflammatory fluid
collection (star)
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vascularisation between the ventricular and cortical sides
of the abscess may explain why deeply located abscesses
predominantly rupture into the ventricular system [17].
Neonatal brain abscesses are characteristically large at the
time of diagnosis, often multiple, often located in the
frontal or parietal lobes, and typically lacking a complete
capsule, which favours rapid enlargement [18, 19]. Focal
cerebritis produces an ill-defined area of T1-hypointensity
and T2-hyperintensity on MRI. There may be faint
contrast-enhancement within the oedematous area. From
early cerebritis to full-blown late capsule-stage abscess,
gradually increased demarcation is seen between the
purulent centre and a peripheral inflammatory capsule.
On MRI, this final stage characteristically shows the
abscess with a highly T1-hypointense and T2-hyperintense
centre, surrounded by a marked, closed, strongly contrast-
enhancing rim. Peripheral oedema is present to a variable
degree in all stages. The presence of haemorrhagic foci is
revealed as focal native T1-hyperintensity. In late-stage
abscesses, DWI is again accurately demonstrating pus
[20–22]. Magnetic resonance spectroscopy has been used
to analyse the central components of abscesses, revealing
firstly the absence of normal brain metabolites (N-acetyl
aspartate, choline, creatine), and secondly, the presence of
residue from anaerobic glycolysis (lactate, lipids, acetate
and succinate) and proteolysis (amino acids) [23, 24].
Viral infection
The estimated incidence of neonatal viral infection, led by
herpes simplex virus (HSV) 1 and 2, is much lower than for
bacteria-induced sepsis, and it varies from 1.6 to 50 per
100,000 live births, with a lower incidence in Europe
compared to the United States. Newborns are infected
through direct contact with contaminated maternal secre-
tions in the birth canal in 85% of cases [25]. In a study
comparing the long-term outcome of treated neonatal
herpes encephalitis, infants infected with HSV-2 had a
higher morbidity [26]. On the one hand, in primary
disseminated HSV disease, the brain becomes secondarily
infected via blood in 60–75% of infected neonates [27]
with a high mortality rate (30%) and neurological sequelae
in 15% of survivors [28]. On the other hand, isolated CNS
disease occurs in 35% of HSV-infected infants and is
probably the result of neuronal spread. In these, despite
adequate therapy, neurological sequelae are present in 70%
of survivors [29]. Neonatal herpes simplex infections
usually demonstrate significant meningeal inflammation,
perivascular cellular infiltration and multiple necrotic foci,
followed by microglial and astrocytic proliferation. While
in older children the limbic and paralimbic cortex are
predominantly involved and haemorrhagic necrosis often
seen [30], neonatal HSV-infection is rarely haemorrhagic.
Temporal and frontal lobes are spared, and lesions can be
demonstrated within the deep and periventricular white
matter with a variable degree of brain swelling. MRI shows
mostly non-specific diffuse hypointensity on T1- and
hyperintensity on T2-weighted images (Fig. 4), while
DWI, showing restricted diffusion in the periventricular
area, is sensitive in the early phase of the disease [31, 32].
In involved areas, magnetic resonance spectroscopy may
reveal a decrease in N-acetyl aspartate, elevated glutamine/
Fig. 3 E. coli meningitis. Subdural fluid over the left cerebral
hemisphere is hyperintense on diffusion-weighted imaging (b-value,
1,000 s/mm2), a hallmark for a beginning purulent collection (double
arrow)
Fig. 4 Herpes simplex virus encephalitis with diffuse white matter
T2-hyperintensity in both parietal lobes (stars) but no signs of cortical
involvement
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glutamate and sometimes the presence of lactate [33]. Only
rarely is there abnormal contrast-enhancement of the
leptomeninges. Perinatal HSV-infection often has a devas-
tating effect on neuronal development and brain function.
Later in the course of disease, cystic encephalomalacia and
atrophy can develop in all supratentorial cortical and
subcortical regions [32–35]. However, HSV-1 infection is
less likely to cause sequelae, whereas HSV-2 infection is
usually associated with microcephaly, seizures, cerebral
palsy and mental retardation [26].
Beside HSV infection, there are many species of
enterovirus (represented mainly by coxsackie B virus
and poliovirus), echovirus and parechovirus, which can
cause severe meningitis and meningoencephalitis in the
neonatal period, with secondary severe neurodevelop-
mental disabilities [36, 37]. Perinatal enteroviral intracra-
nial infection manifests itself most commonly as viral
“aseptic” meningitis (by CSF criteria), caused by primary
viral infection of the meninges and characterised by
inflammatory infiltration of the pia-arachnoid [38]. Much
less common is primary viral encephalitis, caused by
primary infection of brain parenchyma and characterised
by foci of mononuclear lymphocytic meningeal infiltra-
tion, perivascular inflammation and multifocal neuronal
necrosis with glial proliferation. This characteristic has
been documented only for prenatal coxsackie B infection
[14, 39]. Coxsackie B encephalitis has been shown to
affect the anterior horn cells of the spinal cord, the
medulla and pons, and the cerebellum. The most consis-
tently involved structure is the inferior olivary nucleus
[14], whereas the cerebral hemispheres are less frequently
affected [40]. In echo-/parechovirus infections, some
reports have shown focal cerebral white matter necrosis
with consecutive, predominantly periventricular, atrophy,
similar to periventricular leucomalacia [41].
Fungal infection
Systemic fungal infections, usually with Candia albicans,
predominantly affect either extremely preterm neonates
with immature immune systems, or neonates with con-
genital or acquired immunodeficiency [42, 43] (Fig. 5).
One-third of neonatal late-onset sepsis due to Candida
shows signs of CNS involvement [44]. In the last two
decades, perhaps because of earlier recognition or improved
therapy, outcomes have become more favourable, with
mortality rates for neonates and infants much lower than for
older children [45]. Invasive systemic aspergillosis is rare
with only 35 neonatal cases published [42]. However, the
brain is a common site of infection via haematogenous
dissemination from an extra cranial focus, commonly the
lung [46]. Brain aspergillosis in immunocompromised
patients has poor prognosis with a mortality rate approaching
85–100%, and death usually within 1 week of onset of
neurological symptoms [47]. Nevertheless, recent aggressive
antifungal therapies have provided effective treatment. CNS
aspergillosis and candidiasis usually cause one or more
abscesses, but vasculitis and meningoencephalitis can also be
seen. In the disseminated form of brain aspergillosis, hyphae
thrombose arteries and cause brain infarctions that are
commonly haemorrhagic [45]. These infarcts, which have a
predilection for the corticomedullary junction, readily trans-
form into cerebritis or abscess by erosion of the arterial wall
that result in mycotic vasculitis and aneurysm [48].
Involvement of the basal nuclei, thalami and corpus callosum
is also characteristic and reflects the predisposition of
perforating arteries to becoming involved. MRI shows
numerous parenchymal foci throughout the supra and
infratentorial brain, sometimes even within the ventricles
[49] (Fig. 5). Contrast-enhancement appears to depend on
the host’s immune response, and it varies from nodular
enhancement, in the case of small foci, to ring-enhancement
in larger abscesses. During therapy, repeat imaging shows
slow resolution of parenchymal lesions with disappearance
after 6 months [49]. At the corticomedullary junction, focal
T2-hypointensity may represent aspergillus hyphae, fresh
thrombus in the vessels, or small foci of haemorrhage around
the vessels [50].
Fig. 5 Candida meningoencephalitis. Numerous small contrast-
enhancing fungal nodules (arrows) are disseminated throughout the
cerebral hemispheres (Courtesy of Dr Catherine Christophe, MD,
University Children’s Hospital of Queen Fabiola, Brussels, Belgium)
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Conclusion
MRI is an excellent tool for early and accurate detection of
pathological findings in neonatal brain infections. It allows
differentiation of infections from other entities with similar
non-specific clinical symptoms. MRI easily demonstrates
involvement of the ependymal lining, meninges and
parenchyma in early phase. DWI not only enables detection
of ischemic foci, but also of purulent accumulations that are
not readily evident on other sequences. MRI is the modality
of choice not only for early identification of complications,
but also for monitoring treatment.
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